Video

Dr. Grothey on the Role of Precision Medicine in CRC

Axel Grothey, MD, discusses the role of precision medicine in colorectal cancer.

Axel Grothey, MD, medical oncologist and director of Gastrointestinal Cancer Research at West Cancer Center and Research Institute, discusses the role of precision medicine in colorectal cancer (CRC).

With the rise of molecular profiling, the field of CRC has shifted away from a one-size-fits-all approach and entered an era of precision medicine. Notably, molecular profiling guides the treatment selection process and allows for better patient outcomes. As such, it should be utilized across all advanced gastrointestinal malignancies, Grothey says.

A number of targeted agents directed toward specific mutations are available in CRC. These regimens should be used to tailor effective treatment to an individual patient. In addition, these therapies tend to be well tolerated and many patients who receive them are able to maintain a good quality of life, concludes Grothey.

Related Videos
Stephen V. Liu, MD
Eytan M. Stein, MD
Vered Stearns, MD
Michael A. Postow, MD
Dr Patel on the Utility of the IPS Test in Solid Tumors
Suresh Senan, MRCP, FRCR, PhD, full professor, treatment and quality of life, full professor, cancer biology and immunology, full professor, radiation oncology, professor, clinical experimental radiotherapy, Amsterdam University Medical Centers
Alison Schram, MD
Shaji Kumar, MD
Kevin Kalinsky, MD, MS
Guru P. Sonpavde, MD